Cart
sales@molnova.com
Iodofiltic acid
CAS No. 116754-87-1
Iodofiltic acid( —— )
Catalog No. M36184 CAS No. 116754-87-1
Iodofiltic acid can be used in the adjuvant treatment of acute coronary syndromes (Zeus ACS) and can be imaged to detect myocardial ischemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 171 | In Stock |
|
| 10MG | 247 | In Stock |
|
| 25MG | 481 | In Stock |
|
| 50MG | 632 | In Stock |
|
| 100MG | 900 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1795 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIodofiltic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionIodofiltic acid can be used in the adjuvant treatment of acute coronary syndromes (Zeus ACS) and can be imaged to detect myocardial ischemia.
-
DescriptionIodofiltic acid can be used in the adjuvant treatment of acute coronary syndromes (Zeus ACS) and can be imaged to detect myocardial ischemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number116754-87-1
-
Formula Weight458.42
-
Molecular FormulaC22H35IO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CCCCCCCCCCCC(CC(O)=O)C)C1=CC=C(I)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MitoPQ
MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter.
-
Biguanidinium-porphy...
Biguanidinium-porphyrin is a phototoxic agent with anti-proliferative activity.
-
MSH Release Inhibiti...
MIF-1 (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 inhibits melanin formation. MIF-1 blocks the effects of opioid receptor activation to modulate the analgesic effects. MIF-1 accesses from the blood to the CNS by directly crossing the blood-brain barrier (BBB).
